Hope for 21,000 kids: cambodia trial aims to wipe out hepatitis c
NCT ID NCT05992077
First seen Dec 16, 2025 · Last updated May 21, 2026 · Updated 22 times
Summary
This study tests a 12-week treatment with two oral drugs (sofosbuvir and daclatasvir) to cure active hepatitis C in children aged 6 to 17 in Cambodia. About 21,000 participants will take the pills and be monitored to see if the virus is gone 12 weeks after stopping treatment. The goal is to eliminate the infection without need for lifelong medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Battambang Provincial Hospital
Battambang, Cambodia
-
Jayavarman VII Hospital
Siem Reap, Cambodia
-
Kantha Bopha Hospital
Phnom Penh, Cambodia
-
National Pediatric Hospital
Phnom Penh, Cambodia
Conditions
Explore the condition pages connected to this study.